查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2011596

醫療影像設備市場：按產品類型、便攜性、應用和最終用戶分類－2026-2032年全球市場預測

Diagnostic Imaging Equipment Market by Product Type, Portability, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療影像設備市場價值將達到 472.7 億美元，到 2026 年將成長至 500.1 億美元，到 2032 年將達到 717.7 億美元，複合年成長率為 6.14%。

主要市場統計數據
基準年 2025 472.7億美元
預計年份：2026年 500.1億美元
預測年份 2032 717.7億美元
複合年成長率 (%) 6.14%

權威概述了技術創新、不斷變化的臨床需求和營運要求如何重塑診斷成像設備的採用和使用。

診斷影像設備仍然是現代臨床決策的基礎，能夠實現早期發現、更精準的診斷以及在眾多專科領域監測治療進展。儘管電腦斷層掃描 (CT)、磁振造影(MRI)、核子醫學影像、超音波和 X 光等影像技術仍然是臨床流程的重要組成部分，但不斷發展的臨床指南和技術進步正日益影響著這些技術的應用和使用模式。相關人員正面臨著一個複雜的環境，他們必須在臨床療效、病人安全、成本控制和工作流程最佳化之間取得平衡，才能創造可衡量的價值。

人工智慧、即時檢測 (PoC) 模式、混合成像趨勢以及對價值的需求如何從根本上改變診斷成像領域。

診斷影像領域正經歷著一場根本性的變革，這場變革是由技術、臨床和經濟因素共同驅動的。人工智慧（AI）和先進的影像分析技術實現了自動分診、精準的病灶檢測和定量生物標記分析，從而加快了診斷速度並提高了診斷結果的可重複性。同時，混合成像和多模態融合技術將解剖學和功能性數據結合，提高了臨床特異性，從而革新了腫瘤學和神經病學領域的診斷演算法。

該評估旨在評估近期關稅變化如何重塑診斷成像設備整個價值鏈的供應鏈、採購決策和製造策略。

美國於2025年加徵關稅，為診斷影像設備的全球供應鏈和籌資策略帶來了新的複雜性。依賴跨國採購精密零件和半導體相關子系統的製造商面臨投入成本上升和前置作業時間延長的雙重壓力，迫使他們迅速重新評估供應商集中度帶來的風險。為此，許多企業加快了供應商多元化、關鍵子組件近岸生產以及產品重新設計等舉措，以減少對受關稅影響零件的依賴。

從獨特的細分觀點，探討影響策略定位的模式差異化、便攜性與功能性之間的權衡、臨床應用優先順序以及最終用戶的採購行為。

透過對產品類型、便攜性、應用和最終用戶等細分市場的深入分析，可以明確臨床需求與商業性機會的交會點。在產品類型中，電腦斷層掃描 (CT) 系統不斷發展，高切、中切和低切系統之間的區別決定了其應用場景，從高級血管造影到常規急診診斷均有涉及。磁振造影(MRI) 系統分為封閉式系統（針對高磁場強度進行最佳化）和開放式系統（優先考慮患者舒適度和介入治療）。核子醫學掃描術診斷分為 PET 和 SPECT 兩種模式，其中 PET 在分子腫瘤學領域中保持優勢，而 SPECT 則涵蓋更廣泛的心臟病學和功能性影像適應症。超音波診斷設備的臨床應用價值，2D成像用於一般診斷，3D和四維平台用於改善產科和胎兒可視化，多普勒系統用於增強血管和心臟血流效用。 X 光系統正從類比平台向數位放射線攝影過渡，影像工作流程不斷改進，並與 PACS 和報告系統整合。

區域醫療保健基礎設施、監管碎片化和投資重點如何影響全球市場在採納和商業策略方面的差異？

區域趨勢對整個診斷影像產業的普及曲線、監管方式和創新擴散都產生顯著影響。在美洲，完善的醫療基礎設施、集中的供應商市場佔有率和先進的報銷機制促進了高階設備和整合軟體解決方案的快速普及，而成熟的臨床療效和供應商服務品質往往是系統採購的優先考慮因素。在歐洲、中東和非洲，監管體系的片段化和報銷環境的差異導致了普及格局的不平衡。先進治療方法和高階設備在已開發地區表現良好，而其他市場則更注重成本效益高且性能穩定的解決方案。部分地區的政策轉變和集中採購進一步影響定價和競標行為。在亞太地區，對醫療基礎設施的投資、不斷成長的臨床需求以及有利的公共衛生政策正在加速高階設備和可攜式診斷影像解決方案的普及，部分市場對本地生產夥伴關係和以價值為導向的服務交付的需求尤為強勁。

對老牌製造商、敏捷創新者和軟體顛覆者如何透過夥伴關係、服務和模組化產品策略來塑造競爭動態進行了深入分析。

診斷影像領域的競爭格局呈現出多元化的特點，既有成熟的跨國製造商，也有專注於特定領域的創新企業，還有越來越多以「軟體優先」為核心、致力於分析和工作流程最佳化的新興參與企業。現有醫療設備製造商繼續強調軟硬體一體化解決方案、全生命週期服務合約以及融資方案，以降低大規模醫療機構採用這些產品的門檻。同時，中小企業和Start-Ups透過專注於特定臨床應用、推出創新外形規格（例如手持式超音波設備）以及開發可部署為雲端服務的先進影像處理演算法來脫穎而出。

供應商和提供者應採取切實可行、優先考慮且具有策略意義的行動，以推動創新、降低供應鏈風險，並使他們的經營模式與臨床結果保持一致。

產業領導企業應採取多管齊下的策略，平衡創新、供應鏈韌性和以客戶為中心的經營模式。優先投資軟體和分析技術，既能創造差異化的臨床價值，又能透過訂閱服務實現持續收入。同時，供應商多元化、近岸外包或評估區域製造夥伴關係關係，可以降低貿易中斷和投入成本波動帶來的風險。領導者也應重新思考傳統的銷售方式，提供可客製化的資金籌措、基於績效的合約以及全面的管理服務包，使獎勵與醫療服務提供者的績效目標保持一致。

結合相關人員訪談、臨床文獻分析和情境檢驗的穩健混合方法研究途徑，確保了可靠且可操作的見解。

支持這些發現的研究結合了定性和定量方法，採用結構化的調查方法，透過證據三角驗證確保結果的可重複性。主要研究包括對臨床醫生、採購負責人、生物醫學工程師和行業高管進行結構化訪談，從而獲得關於設備使用、維護週期和採購決策標準的第一手觀點。次要研究涵蓋了同行評審的臨床研究、監管指導文件、製造商的技術規範和公開的財務資訊披露，這些資料共同用於評估該技術的成熟度、臨床效用和運營限制。

本文簡要總結了決定診斷成像領域競爭成功和臨床影響的技術、營運和政策因素的融合。

總而言之，診斷影像設備產業正處於一個轉折點，技術進步、醫療服務模式的演變以及價值鏈的現實變化共同作用，重新定義了價值創造。軟體、影像分析和可攜式硬體的創新正在開闢新的臨床應用場景，並推動分散式醫療工作流程的發展。同時，籌資策略也越來越受到整體擁有成本 (TCO)、與臨床結果的契合度以及服務連續性的驅動。貿易政策和關稅的變化凸顯了供應鏈多元化的重要性，加速了區域製造的討論，並為採購和產品設計決策增添了策略維度。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療影像設備市場：依產品類型分類

  • 電腦斷層掃描（CT）掃描儀
    • 高切CT掃描儀
    • 低切CT掃描儀
    • 中切CT掃描儀
  • 磁振造影造影（MRI）
    • 封閉式磁振造影系統
    • 開放式磁振造影系統
  • 核子醫學掃描術診斷設備
    • PET系統
    • SPECT系統
  • 超音波系統
    • 2D超音波系統
    • 3D和4D超音波系統
    • 多普勒超音波系統
  • X光系統
    • 模擬X光系統
    • 數位X光系統

第9章：診斷影像設備市場－便攜性

  • 固定式影像診斷設備
  • 攜帶式影像設備
    • 手持便攜設備
    • 攜帶式設備

第10章：醫療影像設備市場：依應用領域分類

  • 循環系統
    • 冠狀動脈成像
    • 血管影像
  • 神經病學
    • 腦部掃描
    • 脊髓成像
  • 婦產科
    • 胎兒監護
    • 骨盆腔影像診斷
  • 腫瘤學
    • 早期檢測
    • 疾病分期和後續觀察
  • 整形外科
    • 骨折檢測
    • 聯合檢查

第11章 醫療影像設備市場：依最終用戶分類

  • 門診部
  • 診斷影像中心
  • 醫院和診所

第12章 醫療影像設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 醫療影像設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 醫療影像設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國醫療影像設備市場

第16章：中國醫療影像設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agfa-Gevaert Group
  • Analogic Corporation
  • Avonix Imaging, LLC by Nikon Corporation
  • Barco NV
  • Bracco SpA
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips NV
  • Medtronic PLC
  • MinFound Medical Systems Co., Ltd.
  • Neusoft Corporation
  • Planmed Oy
  • Samsung Electronics Co., Ltd
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Stryker Corporation
  • Ziehm Imaging GmbH
Product Code: MRR-43676CF420BD

The Diagnostic Imaging Equipment Market was valued at USD 47.27 billion in 2025 and is projected to grow to USD 50.01 billion in 2026, with a CAGR of 6.14%, reaching USD 71.77 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 47.27 billion
Estimated Year [2026] USD 50.01 billion
Forecast Year [2032] USD 71.77 billion
CAGR (%) 6.14%

An authoritative overview of how technological innovation, clinical demand shifts, and operational imperatives are reshaping diagnostic imaging equipment adoption and use

Diagnostic imaging equipment continues to serve as the backbone of modern clinical decision-making, enabling earlier detection, more accurate diagnoses, and better treatment monitoring across a broad range of specialties. Imaging modalities such as computed tomography, magnetic resonance imaging, nuclear imaging, ultrasound, and X-ray remain integral to care pathways, while evolving clinical guidelines and technological advances are increasingly shaping procurement and utilization patterns. Stakeholders are navigating a complex environment where clinical efficacy, patient safety, cost containment, and workflow optimization must be balanced to deliver measurable value.

Clinical demands are being redefined by a confluence of demographic shifts and rising chronic disease prevalence, which together increase imaging volumes and place renewed emphasis on throughput and efficiency. At the same time, technological innovations-ranging from hardware miniaturization to software-driven image enhancement-are altering the value proposition of equipment investments. Providers and vendors must therefore consider not only capital cost but also lifecycle service models, integration with electronic health records, and the ability to support multidisciplinary care. Given this landscape, executives and clinical leaders need a clear, evidence-based picture of how modality-specific advances, regulatory changes, and reimbursement pressures will influence procurement strategies and operational priorities going forward.

How artificial intelligence, point-of-care modalities, hybrid imaging trends, and value-based imperatives are fundamentally altering the diagnostic imaging landscape

The diagnostic imaging landscape is undergoing fundamental transformation driven by converging technological, clinical, and economic forces. Artificial intelligence and advanced image analytics are enabling automated triage, enhanced lesion detection, and quantitative biomarkers that can accelerate diagnosis while improving reproducibility. Concurrently, hybrid imaging and multimodal integration are increasing clinical specificity by combining anatomical and functional data, which is transforming diagnostic algorithms in oncology and neurology.

Meanwhile, the push toward patient-centric care is promoting portable and point-of-care imaging solutions that decongest centralized radiology suites and bring diagnostic capability closer to bedside and community settings. Value-based reimbursement models are also reshaping purchase and service contracts, with providers placing greater emphasis on demonstrable outcomes, throughput, and total cost of ownership rather than acquisition price alone. Lastly, an increased focus on radiation dose optimization, environmental sustainability, and ergonomic design is influencing both product development and procurement criteria. As a result, companies that align product roadmaps with software-driven workflows, interoperability standards, and flexible commercial models are best positioned to capitalize on these transformative shifts.

Assessing how recent tariff shifts have reshaped supply chains, procurement decisions, and manufacturing strategies across the diagnostic imaging equipment value chain

The implementation of tariffs by the United States in 2025 introduced a new layer of complexity to global diagnostic imaging supply chains and procurement strategies. Manufacturers that relied on cross-border sourcing for precision components and semiconductor-dependent subsystems faced increased input costs and longer lead times, prompting rapid reassessment of supplier concentration risks. In response, many organizations accelerated efforts to diversify suppliers, nearshore production of critical subassemblies, and redesign products to reduce dependence on tariff-impacted parts.

Healthcare providers and equipment distributors experienced pressure to renegotiate purchase terms and service agreements, as cost pressures were often transferred through the supply chain. Capital expenditure committees became more sensitive to total lifecycle cost implications and to the balance between immediate capital outlay and long-term service commitments. At the same time, some vendors pursued vertical integration and strategic partnerships to secure critical inputs and stabilize pricing. Regulatory compliance and customs-related administrative burdens also increased, raising the importance of trade expertise in procurement and contracting. Overall, the tariff environment catalyzed supply chain resilience initiatives, reshaping vendor relationships and accelerating manufacturing localization strategies that will influence procurement negotiation dynamics and product roadmaps in the medium term.

Distinctive segmentation-driven perspectives on modality differentiation, portability trade-offs, clinical application priorities, and end-user procurement behaviors influencing strategic positioning

Interpreting segmentation insights across product type, portability, application, and end-user dimensions provides clarity on where clinical needs and commercial opportunity intersect. Within product categories, computed tomography systems continue to evolve with distinctions between high-slice, mid-slice, and low-slice systems shaping use cases from advanced cross-sectional vascular studies to routine emergency diagnostics. Magnetic resonance imaging equipment remains divided between closed systems optimized for higher field strengths and open systems that prioritize patient comfort and interventional access. Nuclear imaging splits across PET and SPECT modalities, with PET maintaining strength in molecular oncology and SPECT serving broader cardiology and functional imaging indications. Ultrasound retains broad clinical utility with 2D imaging for general diagnostics, 3D and 4D platforms advancing obstetrical and fetal visualization, and Doppler systems enhancing vascular and cardiac flow assessment. X-ray systems continue their transition from analog platforms to digital radiography, improving image workflow and integration with PACS and reporting systems.

Portability defines a separate axis of differentiation, where fixed imaging equipment supports high-throughput centralized services while portable imaging equipment, spanning handheld devices and transportable units, enables decentralized diagnostics and rapid response in emergency or remote settings. Application-driven segmentation reveals modality adoption aligned to clinical domains: cardiology leverages coronary and vascular imaging for interventional planning and follow-up, neurology applies brain and spinal cord imaging for stroke and degenerative disease management, obstetrics and gynecology emphasize fetal monitoring and pelvic imaging, oncology requires early detection and staging plus ongoing monitoring, and orthopedics depends on fracture detection and joint-focused examinations. End-user segmentation likewise informs procurement cadence and service expectations; ambulatory care centers prioritize cost-effective, rapid turnaround systems, diagnostic imaging centers focus on specialized throughput and modality mix, and hospitals and clinics demand versatile, integrated platforms capable of supporting a wide range of acute and elective procedures. Understanding these segment intersections is critical for product positioning, capital planning, and clinical engagement strategies, as modality choice and configuration directly influence clinical workflow, staffing, and downstream revenue generation.

How regional healthcare infrastructure, regulatory fragmentation, and investment priorities are directing differential adoption and commercial strategies across global markets

Regional dynamics exert significant influence on adoption curves, regulatory approaches, and innovation diffusion across the diagnostic imaging industry. In the Americas, established healthcare infrastructure, consolidated vendor footprints, and advanced reimbursement frameworks support rapid uptake of high-end modalities and integrated software solutions, while systems procurement is often tied to demonstrated clinical outcomes and vendor service quality. In Europe, the Middle East & Africa, regulatory fragmentation and heterogeneous reimbursement environments create a patchwork of adoption, where advanced therapies and high-end devices perform strongly in developed pockets while other markets emphasize cost-effective, robust solutions. Policy shifts and centralized purchasing in some jurisdictions further influence pricing and tendering behaviors. In the Asia-Pacific region, investment in healthcare infrastructure, rising clinical demand, and favorable public health initiatives are driving accelerated adoption of both high-end modalities and portable imaging solutions, with several markets showing particular appetite for localized manufacturing partnerships and value-aligned service offerings.

Cross-region supply chain considerations, clinical training availability, and variations in patient demographics all shape how device lifecycles, service models, and aftermarket support are structured. Vendors and providers operating across regions must therefore calibrate product portfolios, financing options, and clinical education programs to local reimbursement realities and infrastructure constraints. Strategic regional partnerships and adaptable go-to-market models are essential to translate global innovation into sustainable regional adoption and to mitigate risks associated with regulatory changes and trade disruptions.

An incisive view of how incumbent manufacturers, nimble innovators, and software disruptors are shaping competitive dynamics through partnerships, services, and modular product strategies

The competitive landscape in diagnostic imaging is characterized by a mix of established multinational manufacturers, specialized niche innovators, and a growing cohort of software-first entrants focused on analytics and workflow optimization. Incumbent device manufacturers continue to emphasize integrated hardware-software bundles, lifecycle service agreements, and financing solutions that reduce adoption friction for large providers. Simultaneously, smaller firms and startups are carving out differentiation through focused clinical applications, disruptive form factors such as handheld ultrasound, and advanced image processing algorithms that can be deployed as cloud-enabled services.

Strategic partnerships, co-development agreements, and targeted acquisitions have emerged as primary levers for both scale and innovation. Many companies are investing in modular architectures that allow incremental feature upgrades, thereby extending product lifespans and creating recurring revenue through software subscriptions and clinical decision support tools. Aftermarket services and managed equipment programs are gaining prominence as revenue-stable offerings that align vendor incentives with provider uptime and performance. As competition intensifies, market leaders are balancing capital-intensive R&D with go-to-market investments in clinical validation, training programs, and customer success teams to accelerate adoption and capture downstream service revenue.

Practical and prioritized strategic actions that vendors and providers should implement to innovate, de-risk supply chains, and align commercial models with clinical outcomes

Industry leaders should adopt a multi-faceted strategy that balances innovation with supply chain resilience and customer-centric commercial models. Prioritizing investments in software and analytics can create differentiated clinical value while enabling recurring revenue through subscription services. At the same time, diversifying supplier bases and evaluating nearshoring or regional manufacturing partnerships will mitigate exposure to trade disruptions and input-cost volatility. Leaders should also reconsider traditional sales approaches by offering configurable financing, outcome-linked contracts, and comprehensive managed-service packages that align incentives with provider performance goals.

Operationally, building strong clinical validation programs and clinician-focused training will accelerate technology adoption and build long-term loyalty. Vendor teams should invest in interoperability and open-architecture designs to ease integration into heterogeneous hospital ecosystems and to support multi-vendor workflows. Finally, companies must integrate sustainability and dose-optimization features into product roadmaps as procurement committees increasingly weigh environmental and patient-safety credentials. By combining technical innovation with flexible commercial models and resilient operations, industry leaders can capture strategic growth while delivering measurable clinical and financial value to customers.

A robust mixed-methods research approach combining stakeholder interviews, clinical literature analysis, and scenario validation to ensure reliable and actionable insights

The research underpinning these insights blended qualitative and quantitative rigor through a structured methodology designed to triangulate evidence and ensure reproducibility. Primary research included structured interviews with clinicians, procurement officers, biomedical engineers, and industry executives, providing frontline perspectives on modality utilization, maintenance cycles, and purchase decision criteria. Secondary research encompassed peer-reviewed clinical studies, regulatory guidance documents, manufacturer technical specifications, and publicly available financial disclosures, which together informed assessments of technology readiness, clinical utility, and operational constraints.

Data synthesis employed cross-validation techniques to reconcile divergent views and to identify consensus trends. Case studies and real-world implementations were analyzed to extract lessons on deployment barriers and success factors. The methodology also incorporated scenario analysis to stress-test strategic assumptions under differing regulatory and supply chain conditions. Limitations were acknowledged, including variations in local reimbursement practices and the dynamic nature of software-driven innovation, and these were addressed through continuous stakeholder engagement and iterative validation cycles to maintain relevance and accuracy.

A concise synthesis of the converging technological, operational, and policy forces that will determine competitive success and clinical impact in diagnostic imaging

In synthesis, the diagnostic imaging equipment sector is at an inflection point where technological advances, shifting care delivery models, and supply chain realities are jointly redefining value creation. Innovations in software, image analytics, and portable hardware are unlocking new clinical use cases and enabling decentralized care workflows, while procurement strategies are increasingly guided by total cost of ownership, clinical outcome linkage, and service continuity. Trade policy and tariff changes have underscored the importance of supply chain diversification and have accelerated regional manufacturing conversations, adding a strategic layer to procurement and product design decisions.

Organizations that successfully integrate product innovation with resilient operations, flexible commercial frameworks, and clinician-centered implementation plans will gain competitive advantage. Moreover, the ability to validate clinical impact, ensure regulatory compliance across jurisdictions, and provide reliable aftermarket services will determine long-term vendor-provider relationships. As the sector continues to evolve, stakeholders should maintain agility in portfolio planning and prioritize investments that deliver demonstrable clinical benefit and operational efficiency across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Diagnostic Imaging Equipment Market, by Product Type

  • 8.1. Computed Tomography (CT) Scanners
    • 8.1.1. High-Slice CT Scanners
    • 8.1.2. Low-Slice CT Scanners
    • 8.1.3. Mid-Slice CT Scanners
  • 8.2. Magnetic Resonance Imaging (MRI) Equipment
    • 8.2.1. Closed MRI Systems
    • 8.2.2. Open MRI Systems
  • 8.3. Nuclear Imaging Equipment
    • 8.3.1. PET Systems
    • 8.3.2. SPECT Systems
  • 8.4. Ultrasound Systems
    • 8.4.1. 2D Ultrasound Systems
    • 8.4.2. 3D & 4D Ultrasound Systems
    • 8.4.3. Doppler Ultrasound Systems
  • 8.5. X-Ray Systems
    • 8.5.1. Analog X-Ray Systems
    • 8.5.2. Digital X-Ray Systems

9. Diagnostic Imaging Equipment Market, by Portability

  • 9.1. Fixed Imaging Equipment
  • 9.2. Portable Imaging Equipment
    • 9.2.1. Handheld Portable Devices
    • 9.2.2. Transportable Equipment

10. Diagnostic Imaging Equipment Market, by Application

  • 10.1. Cardiology
    • 10.1.1. Coronary Imaging
    • 10.1.2. Vascular Imaging
  • 10.2. Neurology
    • 10.2.1. Brain Scans
    • 10.2.2. Spinal Cord Imaging
  • 10.3. Obstetrics & Gynecology
    • 10.3.1. Fetal Monitoring
    • 10.3.2. Pelvic Imaging
  • 10.4. Oncology
    • 10.4.1. Early Detection
    • 10.4.2. Staging & Monitoring
  • 10.5. Orthopedics
    • 10.5.1. Fracture Detection
    • 10.5.2. Joint Examination

11. Diagnostic Imaging Equipment Market, by End-User

  • 11.1. Ambulatory Care Centers
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Hospitals & Clinics

12. Diagnostic Imaging Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Diagnostic Imaging Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Diagnostic Imaging Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Diagnostic Imaging Equipment Market

16. China Diagnostic Imaging Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agfa-Gevaert Group
  • 17.6. Analogic Corporation
  • 17.7. Avonix Imaging, LLC by Nikon Corporation
  • 17.8. Barco NV
  • 17.9. Bracco S.p.A.
  • 17.10. Canon Medical Systems Corporation
  • 17.11. Carestream Health, Inc.
  • 17.12. Esaote S.p.A
  • 17.13. FUJIFILM Holdings Corporation
  • 17.14. GE HealthCare Technologies Inc.
  • 17.15. Hologic, Inc.
  • 17.16. Konica Minolta, Inc.
  • 17.17. Koninklijke Philips N.V.
  • 17.18. Medtronic PLC
  • 17.19. MinFound Medical Systems Co., Ltd.
  • 17.20. Neusoft Corporation
  • 17.21. Planmed Oy
  • 17.22. Samsung Electronics Co., Ltd
  • 17.23. Shanghai United Imaging Healthcare Co., Ltd.
  • 17.24. Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • 17.25. Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
  • 17.26. Shimadzu Corporation
  • 17.27. Siemens Healthineers
  • 17.28. Stryker Corporation
  • 17.29. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 280. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 281. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2032 (USD MILLION)
  • TABLE 283. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 284. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 285. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 286. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 287. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 288. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 289. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD